B Han1, Q Li1, C Wang1, P Chandrasekaran1, Y Zhou2, L Qin3, X S Liu3, M Enomoto-Iwamoto4, D Kong2, R V Iozzo5, D E Birk6, L Han7. 1. School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, 19104, United States. 2. Department of Statistical Sciences, University of Toronto, Toronto, ON, M5S 3G3, Canada. 3. McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States. 4. Department of Orthopaedics, School of Medicine, University of Maryland, Baltimore, MD, 21201, United States. 5. Department of Pathology, Anatomy, and Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, United States. 6. Department of Molecular Pharmacology and Physiology, Morsani School of Medicine, University of South Florida, Tampa, FL, 33612, United States. 7. School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, 19104, United States. Electronic address: lh535@drexel.edu.
Abstract
OBJECTIVE: To delineate the activities of decorin and biglycan in the progression of post-traumatic osteoarthritis (PTOA). DESIGN: Three-month-old inducible biglycan (BgniKO) and decorin/biglycan compound (Dcn/BgniKO) knockout mice were subjected to the destabilization of the medial meniscus (DMM) surgery to induce PTOA. The OA phenotype was evaluated by assessing joint structure and sulfated glycosaminoglycan (sGAG) staining via histology, surface collagen fibril nanostructure and calcium content via scanning electron microscopy, tissue modulus via atomic force microscopy-nanoindentation, as well as subchondral bone structure and meniscus ossification via micro-computed tomography. Outcomes were compared with previous findings in the inducible decorin (DcniKO) knockout mice. RESULTS: In the DMM model, BgniKO mice developed similar degree of OA as the control (0.44 [-0.18 1.05] difference in modified Mankin score), different from the more severe OA phenotype observed in DcniKO mice (1.38 [0.91 1.85] difference). Dcn/BgniKO mice exhibited similar histological OA phenotype as DcniKO mice (1.51 [0.97 2.04] difference vs control), including aggravated loss of sGAGs, salient surface fibrillation and formation of osteophyte. Meanwhile, Dcn/BgniKO mice showed further cartilage thinning than DcniKO mice, resulting in the exposure of underlying calcified tissues and aberrantly high surface modulus. BgniKO and Dcn/BgniKO mice developed altered subchondral trabecular bone structure in both Sham and DMM groups, while DcniKO and control mice did not. CONCLUSION: In PTOA, decorin plays a more crucial role than biglycan in regulating cartilage degeneration, while biglycan is more important in regulating subchondral bone structure. The two have distinct activities and modest synergy in the pathogenesis of PTOA.
OBJECTIVE: To delineate the activities of decorin and biglycan in the progression of post-traumatic osteoarthritis (PTOA). DESIGN: Three-month-old inducible biglycan (BgniKO) and decorin/biglycan compound (Dcn/BgniKO) knockout mice were subjected to the destabilization of the medial meniscus (DMM) surgery to induce PTOA. The OA phenotype was evaluated by assessing joint structure and sulfated glycosaminoglycan (sGAG) staining via histology, surface collagen fibril nanostructure and calcium content via scanning electron microscopy, tissue modulus via atomic force microscopy-nanoindentation, as well as subchondral bone structure and meniscus ossification via micro-computed tomography. Outcomes were compared with previous findings in the inducible decorin (DcniKO) knockout mice. RESULTS: In the DMM model, BgniKO mice developed similar degree of OA as the control (0.44 [-0.18 1.05] difference in modified Mankin score), different from the more severe OA phenotype observed in DcniKO mice (1.38 [0.91 1.85] difference). Dcn/BgniKO mice exhibited similar histological OA phenotype as DcniKO mice (1.51 [0.97 2.04] difference vs control), including aggravated loss of sGAGs, salient surface fibrillation and formation of osteophyte. Meanwhile, Dcn/BgniKO mice showed further cartilage thinning than DcniKO mice, resulting in the exposure of underlying calcified tissues and aberrantly high surface modulus. BgniKO and Dcn/BgniKO mice developed altered subchondral trabecular bone structure in both Sham and DMM groups, while DcniKO and control mice did not. CONCLUSION: In PTOA, decorin plays a more crucial role than biglycan in regulating cartilage degeneration, while biglycan is more important in regulating subchondral bone structure. The two have distinct activities and modest synergy in the pathogenesis of PTOA.
Authors: B Doyran; W Tong; Q Li; H Jia; X Zhang; C Chen; M Enomoto-Iwamoto; X L Lu; L Qin; L Han Journal: Osteoarthritis Cartilage Date: 2016-08-25 Impact factor: 6.576
Authors: Rui Hua; Qingwen Ni; Travis D Eliason; Yan Han; Sumin Gu; Daniel P Nicolella; Xiaodu Wang; Jean X Jiang Journal: Matrix Biol Date: 2020-09-28 Impact factor: 11.583
Authors: Xianrong Zhang; Ji Zhu; Fei Liu; Yumei Li; Abhishek Chandra; L Scott Levin; Frank Beier; Motomi Enomoto-Iwamoto; Ling Qin Journal: Bone Res Date: 2014-08-05 Impact factor: 13.567
Authors: James Melrose; Emily S Fuller; Peter J Roughley; Margaret M Smith; Briedgeen Kerr; Clare E Hughes; Bruce Caterson; Christopher B Little Journal: Arthritis Res Ther Date: 2008-07-14 Impact factor: 5.156
Authors: Mengxi Lv; Yilu Zhou; Shawn W Polson; Leo Q Wan; Meiqing Wang; Lin Han; Liyun Wang; X Lucas Lu Journal: Sci Rep Date: 2019-01-14 Impact factor: 4.379
Authors: Prashant Chandrasekaran; Bryan Kwok; Biao Han; Sheila M Adams; Chao Wang; Daphney R Chery; Robert L Mauck; Nathaniel A Dyment; X Lucas Lu; David B Frank; Eiki Koyama; David E Birk; Lin Han Journal: Matrix Biol Date: 2021-07-24 Impact factor: 10.447